Contrast-enhanced ultrasound identifies early extrahepatic collateral contributing to residual hepatocellular tumor viability after transarterial chemoembolization

The mainstay of treatment for unresectable hepatocellular carcinoma is locoregional therapy including percutaneous ablation and transarterial chemo- and radioembolization. While monitoring for tumor response after transarterial chemoembolization is crucial, current imaging strategies are suboptimal....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Radiol Case Rep
Hlavní autoři: Gummadi, Sriharsha, Stanczak, Maria, Lyshchik, Andrej, Forsberg, Flemming, Shaw, Colette M., Eisenbrey, John R.
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2018
Témata:
Sonography
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5930180/
https://ncbi.nlm.nih.gov/pubmed/29721125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radcr.2018.04.001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky